Organization

Clinical Research Centre

5 clinical trials

12 abstracts

Abstract
First-in-human trial of tocilizumab in combination with a standard induction chemotherapy in newly diagnosed acute myeloid leukemia patients: The phase 1 TOCILAM study.
Org: CHU de Nantes, Hôpital Hôtel-Dieu, Nantes, France, Service d'Hématologie Clinique - CHU Pontchaillou, Hotel Dieu - HME, Clinical Research Centre, Departmental Hospital Centre,
Abstract
A META-ANALYSIS OF ANALGESIC EFFICACY OF ROFECOXIB 50 MG FROM 13 CLINICAL STUDIES
Org: Clinical Research Centre, SCIREX Corporation, Austin Health, Clinical Development, Late-Stage Development, Oncology R&D, AstraZeneca, Merck and Co., Inc.,
Abstract
ASSESSMENT OF TREATMENT SATISFACTION AMONG PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS IN A DOUBLE-BLIND TRIAL OF ETANERCEPT AND METHOTREXATE, ALONE AND COMBINED (TEMPO TRIAL)
Org: GHOA, Wyeth Research, Collegeville, PA, United States Army Research Institute of Environmental Medicine, Rheumatology, Society of Patients with Rheumatism, Cracow, Poland,
Abstract
ANTIBODY RESPONSE TO TERIPARATIDE 20 MCG: TREATMENT AND FOLLOW-UP
Org: Clinical Research Centre, Statistics Division, Medical Communications, Eli Lilly and Company, Indianapolis, IN,
Abstract
AUTOANTIBODIES TO CYCLIC CITRULLINATED PEPTIDE 2 (CCP2) ARE SUPERIOR TO OTHER POTENTIAL DIAGNOSTIC BIOMARKERS FOR PREDICTING DEVELOPMENT OF RHEUMATOID ARTHRITIS (RA) IN EARLY UNDIFFERENTIATED ARTHRITIS
Org: Rheumatology, Society of Patients with Rheumatism, Cracow, Poland, Allergy Therapeutics, Clinical Research Centre, Cardiology Unit, IRCCS Humanitas Research Hospital, Rozzano (Milano), Italy, NHO Osaka-Minami Medical Center,
Abstract
ANALGESIC EFFICACY OF SINGLE DOSE ROFECOXIB 50 MG AND MULTIDOSE OXYCODONE/PARACETAMOL IN PATIENTS WITH MODERATE VERSUS SEVERE PAIN
Org: Clinical Research Centre, SCIREX Corporation, Austin Health, Clinical Development, Late-Stage Development, Oncology R&D, AstraZeneca, Merck and Co Inc,
Abstract
ASSOCIATION OF SERUM ANTIBODY RESPONSES TO PORPHYROMONAS GINGIVALIS AND PERIODONTAL CONDITIONS WITH CLINICAL RESPONSE TO BIOLOGICS IN RHEUMATOID ARTHRITIS PATIENTS
Org: Rheumatology, NHO Osaka Minami Medical Center, Osaka, Division of Periodontology, Department of Oral Biological Science, Niigata University, Graduate School of Medical and Dental Sciences, Niigata, Second department of oral and maxillofacial surgery, Osaka Dental University, Clinical Research Centre, Allergology, NHO Osaka Minami Medical Center, Osaka, Japan,
Abstract
AURICULAR TRANSCUTANEOUS HI-FREQUENCY E-MMUNOTHERAPY SEQUENCES (ATHENS) FOR THE TREATMENT OF RHEUMATOID ARTHRITIS: 1-YEAR CHANGES IN SYNOVITIS, OSTEITIS, AND BONE EROSION
Org: Spire Sciences, Inc, Boca Raton, United States, Clinical Research Centre, Boca Raton Regional Hospital, United States of America, Nesos Corp,
Abstract
ASSOCIATIONS BETWEEN METABOLIC STATUS AND ALL-CAUSE MORTALITY AMONG INDIVIDUALS WITH OSTEOARTHRITIS: A PROSPECTIVE COHORT STUDY FROM THE UK BIOBANK AND NHANES DATASETS
Org: Zhujiang Hospital, Southern Medical University, Clinical Research Centre, General Hospital of Southern Theater Command of PLA, Department of Orthopedics, Clinical Research Centre, Guangzhou, China, The Hong Kong Polytechnic University,
Abstract
ASSOCIATION OF HEALTHY LIFESTYLES WITH ALL-CAUSE AND CAUSE-SPECIFIC MORTALITY AMONG INDIVIDUALS WITH OSTEOARTHRITIS: A PROSPECTIVE COHORT STUDY OF THE UK BIOBANK
Org: Zhujiang Hospital, Southern Medical University, Clinical Research Centre, Guangzhou JOYO Pharma, China National Biotec Group,